BMC Res Notes. 2011 May 26;4:163. doi: 10.1186/1756-0500-4-163.
Idiopathic pancreatitis is a consequence of an altering spectrum of bile nucleation time.
BMC research notes
V Abeysuriya, Ki Deen, Bk Dassanayake, Sk Kumarage, Nmm Navarathne, A Pathirana
PMID: 21615942
PMCID: PMC3123218 DOI: 10.1186/1756-0500-4-163
Abstract
BACKGROUND: The pathogenesis of idiopathic pancreatitis (IP) remains poorly understood. Our hypothesis is that IP is a sequel of micro-crystallization of hepatic bile.
METHODS: A prospective case control study compared 55 patients; symptomatic cholelithiasis - 30 (14 male, median age 36 years; mean BMI - 25.1 kg/m2), gallstone pancreatitis - 9 (3 male, median age 35 years; mean BMI - 24.86 kg/m2 ) and IP - 16 (9 male, median age 34 years; mean BMI -23.34 kg/m2) with 30 controls (15 male, median age 38 years; mean BMI = 24.5 kg/m2) undergoing laparotomy for conditions not related to the gall bladder and bile duct. Ultrafiltered bile from the common hepatic duct in patients and controls was incubated in anaerobic conditions and examined by polarized light microscopy to assess bile nucleation time (NT). In the analysis, the mean NT of patients with gallstones and gallstone pancreatitis was taken as a cumulative mean NT for those with established gallstone disease (EGD).
RESULTS: Patients were similar to controls. Mean NT in all groups of patients was significantly shorter than controls (EGD cumulative mean NT, 1.73 +/- 0.2 days vs. controls, 12.74 +/- 0.4 days, P = 0.001 and IP patients mean NT, 3.1 +/- 0.24 days vs. controls, 12.74 +/- 0.4 days, P = 0.001). However, NT in those with IP was longer compared with those with EGD (mean NT in IP, 3.1 +/- 0.24 days vs. cumulative mean in EGD: 1.73 +/- 0.2 days, P = 0.002).
CONCLUSION: Nucleation time of bile in patients with IP is abnormal and is intermediate to nucleation time of lithogenic bile at one end of the spectrum of lithogenicity and non-lithogenic bile, at the other end.
References
- Rev Med Chil. 1997 Aug;125(8):869-78 - PubMed
- N Engl J Med. 1993 Feb 11;328(6):412-21 - PubMed
- Gastrointest Endosc. 2002 Feb;55(2):163-6 - PubMed
- N Engl J Med. 2006 Dec 21;355(25):2670-6 - PubMed
- Curr Gastroenterol Rep. 2005 May;7(2):132-40 - PubMed
- Biochim Biophys Acta. 1992 Jan 16;1138(1):41-5 - PubMed
- Eur J Gastroenterol Hepatol. 2008 Oct;20(10):1020-3 - PubMed
- Br J Surg. 1988 May;75(5):450-3 - PubMed
- Arq Gastroenterol. 2000 Apr-Jun;37(2):93-101 - PubMed
- Gastroenterol Clin Biol. 1984 Mar;8(3):260-3 - PubMed
- Trop Gastroenterol. 2001 Oct-Dec;22(4):205-6 - PubMed
- Scand J Gastroenterol. 1988 Oct;23(8):948-54 - PubMed
- Gastroenterology. 1991 Dec;101(6):1701-9 - PubMed
- J Gastroenterol Hepatol. 2004 Oct;19(10):1206-11 - PubMed
- Gut. 1997 Aug;41(2):138-41 - PubMed
- N Engl J Med. 1992 Feb 27;326(9):589-93 - PubMed
- Gastroenterology. 1988 Nov;95(5):1339-43 - PubMed
- Rev Esp Enferm Dig. 1997 Nov;89(11):843-54 - PubMed
- Gastrointest Endosc. 2002 Feb;55(2):157-62 - PubMed
- Ceylon Med J. 2005 Mar;50(1):5-10 - PubMed
Publication Types